Journal Home
Search for

Volume 34, Issue 2, Pages 119-126 (February 2008)


View previous. 6 of 14 View next.

Weight Management Using the Internet: A Randomized Controlled Trial

Christine M. Hunter, PhDaCorresponding Author Informationemail address, Alan L. Peterson, PhDbc, Lisa M. Alvarez, PhDcg, Walker C. Poston, PhD, MPHd, Antoinette R. Brundige, MScg, C. Keith Haddock, PhDd, David L. Van Brunt, PhDef, John P. Foreyt, PhDg

Background

Most weight-loss research targets obese individuals who desire large weight reductions. However, evaluation of weight-gain prevention in overweight individuals is also critical as most Americans become obese as a result of a gradual gain of 1–2 pounds per year over many years.

Method

This study evaluated the efficacy of an Internet-based program for weight-loss and weight-gain prevention with a two-group, prospective, randomized controlled trial. A military medical research center with a population of 17,000 active-duty military personnel supplied 446 overweight individuals (222 men; 224 women) with a mean age of 34 years and a mean BMI of 29. Recruitment and study participation occurred 2003–2005 and data were analyzed in 2006. Participants were randomly assigned to receive the 6-month behavioral Internet treatment (BIT, n=227) or usual care (n=224). Change in body weight, BMI, percent body fat, and waist circumference; presented as group by time interactions, were measured.

Results

After 6 months, completers who received BIT lost 1.3 kg while those assigned to usual care gained 0.6 kg (F(df=366)=24.17; I<0.001). Results were similar for the intention-to-treat model. BIT participants also had significant changes in BMI (–0.5 vs +0.2 kg/m2; F(df=366)=24.58); percent body fat (–0.4 vs +0.6%; F(df=366)=10.45); and waist circumference (–2.1 vs –0.4 cm; F(df=366)=17.09); p<0.001 for all.

Conclusions

Internet-based weight-management interventions result in small amounts of weight loss, prevent weight gain, and have potential for widespread dissemination as a population health approach.

Trial Registration

NCT00417599.

a Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland

b University of Texas Health Science Center, San Antonio, Texas

c Department of Psychology, Wilford Hall Medical Center, San Antonio, Texas

d University of Missouri, Kansas City School of Medicine, Kansas City, Missouri

e University of Tennessee Health Sciences Center, Memphis, Tennessee

f Eli Lilly and Company, Indianapolis, Indiana

g Baylor College of Medicine, Houston, Texas

Corresponding Author InformationAddress correspondence and reprint requests to: Christine M. Hunter, PhD, Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 605 MCS 5460, Bethesda MD 20892.

PII: S0749-3797(07)00646-0

doi:10.1016/j.amepre.2007.09.026


View previous. 6 of 14 View next.